3bvn › Citations

Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.

Kumar P, Vahedi-Faridi A, Saenger W, Merino E, López de Castro JA, Uchanska-Ziegler B, Ziegler A
J Biol Chem 284 29784-97 (2009)
Related entries: 3bp4, 3bp7, 3bxn

Cited: 33 times
EuropePMC logo PMID: 19617632

Abstract

The existence of cytotoxic T cells (CTL) cross-reacting with the human major histocompatibility antigens HLA-B14 and HLA-B27 suggests that their alloreactivity could be due to presentation of shared peptides in similar binding modes by these molecules. We therefore determined the crystal structures of the subtypes HLA-B*1402, HLA-B*2705, and HLA-B*2709 in complex with a proven self-ligand, pCatA (peptide with the sequence IRAAPPPLF derived from cathepsin A (residues 2-10)), and of HLA-B*1402 in complex with a viral peptide, pLMP2 (RRRWRRLTV, derived from latent membrane protein 2 (residues 236-244) of Epstein-Barr virus). Despite the exchange of 18 residues within the binding grooves of HLA-B*1402 and HLA-B*2705 or HLA-B*2709, the pCatA peptide is presented in nearly identical conformations. However, pLMP2 is displayed by HLA-B*1402 in a conformation distinct from those previously found in the two HLA-B27 subtypes. In addition, the complexes of HLA-B*1402 with the two peptides reveal a nonstandard, tetragonal mode of the peptide N terminus anchoring in the binding groove because of the exchange of the common Tyr-171 by His-171 of the HLA-B*1402 heavy chain. This exchange appears also responsible for reduced stability of HLA-B14-peptide complexes in vivo and slow assembly in vitro. The studies with the pCatA peptide uncover that CTL cross-reactive between HLA-B14 and HLA-B27 might primarily recognize the common structural features of the bound peptide, thus neglecting amino acid replacements within the rim of the binding grooves. In contrast, structural alterations between the three complexes with the pLMP2 peptide indicate how heavy chain polymorphisms can influence peptide display and prevent CTL cross-reactivity between HLA-B14 and HLA-B27 antigens.

Articles - 3bvn mentioned but not cited (9)

  1. Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity. Bassani-Sternberg M, Chong C, Guillaume P, Solleder M, Pak H, Gannon PO, Kandalaft LE, Coukos G, Gfeller D. PLoS Comput Biol 13 e1005725 (2017)
  2. Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens. Kumar P, Vahedi-Faridi A, Saenger W, Merino E, López de Castro JA, Uchanska-Ziegler B, Ziegler A. J Biol Chem 284 29784-29797 (2009)
  3. Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions. Luo H, Du T, Zhou P, Yang L, Mei H, Ng H, Zhang W, Shu M, Tong W, Shi L, Mendrick DL, Hong H. Comb Chem High Throughput Screen 18 296-304 (2015)
  4. Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim-Sulfamethoxazole Induced Liver Injury. Li YJ, Phillips EJ, Dellinger A, Nicoletti P, Schutte R, Li D, Ostrov DA, Fontana RJ, Watkins PB, Stolz A, Daly AK, Aithal GP, Barnhart H, Chalasani N, Drug-induced Liver Injury Network. Hepatology 73 268-281 (2021)
  5. Structural Comparison Between MHC Classes I and II; in Evolution, a Class-II-Like Molecule Probably Came First. Wu Y, Zhang N, Hashimoto K, Xia C, Dijkstra JM. Front Immunol 12 621153 (2021)
  6. The Structure of a Peptide-Loaded Shark MHC Class I Molecule Reveals Features of the Binding between β2-Microglobulin and H Chain Conserved in Evolution. Wu Y, Zhang N, Wei X, Lu S, Li S, Hashimoto K, Dijkstra JM, Xia C. J Immunol 207 308-321 (2021)
  7. Immunoinformatic approach to assess SARS-CoV-2 protein S epitopes recognised by the most frequent MHC-I alleles in the Brazilian population. Moura RR, Agrelli A, Santos-Silva CA, Silva N, Assunção BR, Brandão L, Benko-Iseppon AM, Crovella S. J Clin Pathol 74 528-532 (2021)
  8. The same major histocompatibility complex polymorphism involved in control of HIV influences peptide binding in the mouse H-2Ld system. Narayanan S, Kranz DM. J Biol Chem 288 31784-31794 (2013)
  9. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities. Olson TS, Frost BF, Duke JL, Dribus M, Xie HM, Prudowsky ZD, Furutani E, Gudera J, Shah YB, Ferriola D, Dinou A, Pagkrati I, Kim S, Xu Y, He M, Zheng S, Nijim S, Lin P, Xu C, Nakano TA, Oved JH, Carreno BM, Bolon YT, Gadalla SM, Marsh SG, Paczesny S, Lee SJ, Monos DS, Shimamura A, Bertuch AA, Gragert L, Spellman SR, Babushok DV. JCI Insight 7 e163040 (2022)


Reviews citing this publication (5)

  1. Recent advances in Takayasu arteritis. Terao C, Yoshifuji H, Mimori T. Int J Rheum Dis 17 238-247 (2014)
  2. Revival of the identification of cytotoxic T-lymphocyte epitopes for immunological diagnosis, therapy and vaccine development. Liu J, Zhang S, Tan S, Zheng B, Gao GF. Exp Biol Med (Maywood) 236 253-267 (2011)
  3. Old and new HLA associations with ankylosing spondylitis. Díaz-Peña R, López-Vázquez A, López-Larrea C. Tissue Antigens 80 205-213 (2012)
  4. Structural and dynamic features of HLA-B27 subtypes. Uchanska-Ziegler B, Ziegler A, Schmieder P. Curr Opin Rheumatol 25 411-418 (2013)
  5. Three-Dimensional Portable Document Format (3D PDF) in Clinical Communication and Biomedical Sciences: Systematic Review of Applications, Tools, and Protocols. Newe A, Becker L. JMIR Med Inform 6 e10295 (2018)

Articles citing this publication (19)

  1. Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1. Cortes A, Pulit SL, Leo PJ, Pointon JJ, Robinson PC, Weisman MH, Ward M, Gensler LS, Zhou X, Garchon HJ, Chiocchia G, Nossent J, Lie BA, Førre Ø, Tuomilehto J, Laiho K, Bradbury LA, Elewaut D, Burgos-Vargas R, Stebbings S, Appleton L, Farrah C, Lau J, Haroon N, Mulero J, Blanco FJ, Gonzalez-Gay MA, Lopez-Larrea C, Bowness P, Gaffney K, Gaston H, Gladman DD, Rahman P, Maksymowych WP, Crusius JB, van der Horst-Bruinsma IE, Valle-Oñate R, Romero-Sánchez C, Hansen IM, Pimentel-Santos FM, Inman RD, Martin J, Breban M, Wordsworth BP, Reveille JD, Evans DM, de Bakker PI, Brown MA. Nat Commun 6 7146 (2015)
  2. The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands. Gfeller D, Guillaume P, Michaux J, Pak HS, Daniel RT, Racle J, Coukos G, Bassani-Sternberg M. J Immunol 201 3705-3716 (2018)
  3. Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition. Theodossis A, Guillonneau C, Welland A, Ely LK, Clements CS, Williamson NA, Webb AI, Wilce JA, Mulder RJ, Dunstone MA, Doherty PC, McCluskey J, Purcell AW, Turner SJ, Rossjohn J. Proc Natl Acad Sci U S A 107 5534-5539 (2010)
  4. The role of HLA-B27 in spondyloarthritis. Taurog JD. J Rheumatol 37 2606-2616 (2010)
  5. F pocket flexibility influences the tapasin dependence of two differentially disease-associated MHC Class I proteins. Abualrous ET, Fritzsche S, Hein Z, Al-Balushi MS, Reinink P, Boyle LH, Wellbrock U, Antoniou AN, Springer S. Eur J Immunol 45 1248-1257 (2015)
  6. HLA-B27 heavy chains distinguished by a micropolymorphism exhibit differential flexibility. Fabian H, Huser H, Loll B, Ziegler A, Naumann D, Uchanska-Ziegler B. Arthritis Rheum 62 978-987 (2010)
  7. Association of Takayasu arteritis with HLA-B 67:01 and two amino acids in HLA-B protein. Terao C, Yoshifuji H, Ohmura K, Murakami K, Kawabata D, Yurugi K, Tazaki J, Kinoshita H, Kimura A, Akizuki M, Kawaguchi Y, Yamanaka H, Miura Y, Maekawa T, Saji H, Mimori T, Matsuda F. Rheumatology (Oxford) 52 1769-1774 (2013)
  8. Multiple HLA epitopes contribute to type 1 diabetes susceptibility. Roark CL, Anderson KM, Simon LJ, Schuyler RP, Aubrey MT, Freed BM. Diabetes 63 323-331 (2014)
  9. Research Support, Non-U.S. Gov't Leaving the structural ivory tower, assisted by interactive 3D PDF. Kumar P, Ziegler A, Grahn A, Hee CS, Ziegler A. Trends Biochem Sci 35 419-422 (2010)
  10. HLA-B*13:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population. Yang F, Gu B, Zhang L, Xuan J, Luo H, Zhou P, Zhu Q, Yan S, Chen SA, Cao Z, Xu J, Xing Q, Luo X. Pharmacogenomics 15 1461-1469 (2014)
  11. Influence of inflammation-related changes on conformational characteristics of HLA-B27 subtypes as detected by IR spectroscopy. Fabian H, Loll B, Huser H, Naumann D, Uchanska-Ziegler B, Ziegler A. FEBS J 278 1713-1727 (2011)
  12. The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine. Fontana RJ, Cirulli ET, Gu J, Kleiner D, Ostrov D, Phillips E, Schutte R, Barnhart H, Chalasani N, Watkins PB, Hoofnagle JH. J Hepatol 69 1317-1325 (2018)
  13. An interactive three dimensional approach to anatomical description-the jaw musculature of the Australian laughing kookaburra (Dacelo novaeguineae). Quayle MR, Barnes DG, Kaluza OL, McHenry CR. PeerJ 2 e355 (2014)
  14. Letter Ankylosing spondylitis in three Sub-Saharan populations: HLA-B*27 and HLA-B*14 contribution. Díaz-Peña R, Ouédraogo DD, López-Vázquez A, Sawadogo SA, López-Larrea C. Tissue Antigens 80 14-15 (2012)
  15. Computational characterization of residue couplings and micropolymorphism-induced changes in the dynamics of two differentially disease-associated human MHC class-I alleles. Serçinoğlu O, Ozbek P. J Biomol Struct Dyn 36 724-740 (2018)
  16. Cyclophilin C Participates in the US2-Mediated Degradation of Major Histocompatibility Complex Class I Molecules. Chapman DC, Stocki P, Williams DB. PLoS One 10 e0145458 (2015)
  17. A novel HLA-B*14 allele - B*14:53 - genetics and serology. Street J, Davies E, Darke C. Int J Immunogenet 43 236-239 (2016)
  18. Distinct mechanisms survey the structural integrity of HLA-B*27:05 intracellularly and at the surface. Hein Z, Borchert B, Abualrous ET, Springer S. PLoS One 13 e0200811 (2018)
  19. Epitopes and motifs of the HLA-B*14 allele family products and related HLA-B14 cross-reactive specificities. Street J, Darke C. Int J Immunogenet 44 225-233 (2017)


Related citations provided by authors (1)

  1. Expression, purification and preliminary X-ray crystallographic analysis of the human major histocompatibility antigen HLA-B*1402 in complex with a viral peptide and with a self-peptide.. Kumar P, Vahedi-Faridi A, Merino E, López de Castro JA, Volz A, Ziegler A, Saenger W, Uchanska-Ziegler B Acta Crystallogr Sect F Struct Biol Cryst Commun 63 631-4 (2007)

Quick links